Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Concentration of Trimethylamine Oxide (TMAO) in Blood Plasma as a Risk Factor for Vascular Cerebral Damage

NCT03903601 is registered in ClinicalTrials.gov with Gdansk University of Physical Education and Sport as lead sponsor.

NCT NCT03903601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03903601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Concentration of Trimethylamine Oxide (TMAO) in Blood Plasma as a Risk Factor for Vascular Cerebral Damage
Lead sponsor
Gdansk University of Physical Education and Sport
Phase
Observational
Overall status
Unknown status
Start date
December 30, 2021
Completion date
May 31, 2022
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemia, cerebral, leukoaraiosis, vascular diseases